Article

DLK may induce fewer aberrations than PK, study finds

Paris—Deep lamellar keratoplasty (DLK) seems to be more optically beneficial because of the significant differences in higher-order aberrations induced by DLK compared with penetrating keratoplasty (PK), according to Thomas John, MD.

Dr. John reported his findings at the annual meeting of the European Society of Cataract and Refractive Surgeons. He and colleague Raymond Corwin, MD, compared the topography, aberrometry, and refractive values from patients who underwent PK (n = 10) and DLK (n = 8) with those values from normal controls (n = 48). The investigators measured coma, trefoil, higher-order aberrations, and tilt.

In the DLK group, Dr. John, from Loyola University at Chicago, reported that all the parameters measured, calculated in a 4-mm zone, were decreased and that their topographic features were closer to those of the normal controls compared with the values in the eyes that underwent PK.

There was also a significant decrease in higher-order aberrations in data calculated from 4.8-mm zones in the patients who underwent DLK compared with the patients who underwent PK. The reasons for these differences are that in DLK no corneal wound is created and no sutures are used.

"Wavefront aberrations are much lower after DLK compared with PK. These differences in wavefront aberrations between the two procedures are significant and have a profound effect on glare, contrast, visual acuity, and perception," Dr. John stated.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
© 2025 MJH Life Sciences

All rights reserved.